CTKB
Cytek Biosciences Inc
5.70$
-0.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +21.3% | -23.0% | +3.9% | +10.5% | +11.6% | -27.9% | +10.0% | +14.7% | +18.8% | -29.0% | +9.1% | – | |
| – | +21.0% | -13.3% | -3.0% | +6.2% | +5.9% | -10.6% | +2.0% | +13.8% | +18.2% | -21.8% | -13.5% | – | |
| – | +21.6% | -30.4% | +10.5% | +14.0% | +16.0% | -40.1% | +18.4% | +15.4% | +19.4% | -35.4% | +33.3% | – | |
| – | -2.7% | -9.9% | +2.1% | -1.2% | -1.6% | +0.0% | -9.2% | +1.5% | +0.1% | +7.2% | +1.4% | – | |
| – | +3.9% | +6.1% | +2.5% | -6.4% | -17.1% | +42.2% | +4.9% | +19.1% | +1.6% | +12.7% | -8.9% | – | |
| – | -1.2% | +1.7% | +0.6% | -2.1% | -7.8% | +14.6% | -1.8% | +6.5% | +4.7% | +3.2% | +0.1% | – | |
| – | – | – | – | – | – | -601.5% | – | – | – | – | – | – | |
| – | -33.8% | +11.9% | -69.6% | -11.2% | +483.2% | -58.1% | +42.3% | +19.3% | +46.8% | -63.9% | +7.3% | – | |
| – | – | -318.8% | – | – | +6,475.2% | -209.1% | – | – | – | – | – | – | |
| – | -161.3% | – | – | -124.1% | – | -80.0% | -976.5% | – | – | -96.3% | -65.5% | – | |
| – | – | -212.1% | – | – | +924.8% | -218.2% | – | – | – | – | – | – | |
| – | – | -187.9% | – | – | -179.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.